1. MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom;
2. Center for Modeling, Planning and Policy Analysis, Avenir Health, Glastonbury, CT;
3. Department of Epidemiology and Biostatistics, School of Population and Global Health, McGill University, Montréal, Canada;
4. HIV Prevention Trials Network Modelling Centre, Imperial College London, London, United Kingdom;
5. Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom;
6. United Kingdom Heath Security Agency, London, United Kingdom;
7. Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia;
8. Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa;
9. Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada;
10. MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Canada;
11. Population Health Sciences, University of Bristol, Bristol, United Kingdom;
12. Department of Population Health, New York University Grossman School of Medicine, New York, NY;
13. Data for Impact, The Joint United Nations Program on HIV/AIDS (UNAIDS), Geneva, Switzerland;
14. Department of Nursing and Community Health, Glasgow Caledonian University London, London, United Kingdom;
15. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA;
16. Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD;
17. School of Health and Related Research (SchARR), University of Sheffield, Sheffield, United Kingdom; and
18. Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA.